Literature DB >> 18637131

The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.

Urszula Brudnik1, Wojciech Branicki, Anna Wojas-Pelc, Piotr Kanas.   

Abstract

In this study, we assessed the role of melanocortin-1 receptor (MC1R) and agouti signalling protein (ASIP) polymorphisms in cutaneous melanoma and basal cell carcinoma (BCC) development in a Polish population. We enrolled 108 patients with skin malignant melanoma (MM) and 102 patients with BCC. The control group consisted of 93 non-red haired patients, without history of skin cancers and 30 healthy individuals with red hair colour (RHC) phenotype. The complete MC1R exon was sequenced and the A8818G polymorphism of the ASIP gene was analysed using the SnaPshot protocol. Selected MC1R mutations were additionally examined using a convenient minisequencing assay. The study confirmed the important role of MC1R R variants in determining physiological variation in hair and skin colour. Our data show that individuals with R mutations had a 3.7-fold increase in melanoma risk and a 3.3-fold increase in BCC risk. Especially, variant R151C significantly increased the risk of both MM and BCC. The studied ASIP polymorphism was found not to be associated with MM or BCC. Stratified analysis showed that the association between MC1R mutations and the risk of MM and BCC was not significantly influenced by subjects' pigmentation characteristics or the 8818G ASIP variant. Further research is necessary, especially involving analysis of interactions between variation in MC1R and other genes, to find out if analysis of MC1R polymorphisms could be of any importance for skin cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18637131     DOI: 10.1111/j.1600-0625.2008.00760.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

1.  Association of the SLC45A2 gene with physiological human hair colour variation.

Authors:  Wojciech Branicki; Urszula Brudnik; Jolanta Draus-Barini; Tomasz Kupiec; Anna Wojas-Pelc
Journal:  J Hum Genet       Date:  2008-09-20       Impact factor: 3.172

2.  Model-based prediction of human hair color using DNA variants.

Authors:  Wojciech Branicki; Fan Liu; Kate van Duijn; Jolanta Draus-Barini; Ewelina Pośpiech; Susan Walsh; Tomasz Kupiec; Anna Wojas-Pelc; Manfred Kayser
Journal:  Hum Genet       Date:  2011-01-04       Impact factor: 4.132

3.  Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer.

Authors:  Jürgen Bauer; Julie Weng; Electron Kebebew; Paula Soares; Vitor Trovisco; Boris C Bastian
Journal:  Exp Dermatol       Date:  2009-06       Impact factor: 3.960

4.  Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies.

Authors:  Sara Raimondi; Sara Gandini; Maria Concetta Fargnoli; Vincenzo Bagnardi; Patrick Maisonneuve; Claudia Specchia; Rajiv Kumar; Eduardo Nagore; Jiali Han; Johan Hansson; Peter A Kanetsky; Paola Ghiorzo; Nelleke A Gruis; Terry Dwyer; Leigh Blizzard; Ricardo Fernandez-de-Misa; Wojciech Branicki; Tadeusz Debniak; Niels Morling; Maria Teresa Landi; Giuseppe Palmieri; Gloria Ribas; Alexander Stratigos; Lynn Cornelius; Tomonori Motokawa; Sumiko Anno; Per Helsing; Terence H Wong; Philippe Autier; José C García-Borrón; Julian Little; Julia Newton-Bishop; Francesco Sera; Fan Liu; Manfred Kayser; Tamar Nijsten
Journal:  BMC Med Res Methodol       Date:  2012-08-03       Impact factor: 4.615

5.  MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project.

Authors:  E Tagliabue; M C Fargnoli; S Gandini; P Maisonneuve; F Liu; M Kayser; T Nijsten; J Han; R Kumar; N A Gruis; L Ferrucci; W Branicki; T Dwyer; L Blizzard; P Helsing; P Autier; J C García-Borrón; P A Kanetsky; M T Landi; J Little; J Newton-Bishop; F Sera; S Raimondi
Journal:  Br J Cancer       Date:  2015-06-23       Impact factor: 7.640

6.  Variants of SCARB1 and VDR Involved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell Carcinoma.

Authors:  Ewelina Pośpiech; Janusz Ligęza; Wacław Wilk; Aniela Gołas; Janusz Jaszczyński; Andrzej Stelmach; Janusz Ryś; Aleksandra Blecharczyk; Anna Wojas-Pelc; Jolanta Jura; Wojciech Branicki
Journal:  Biomed Res Int       Date:  2015-04-06       Impact factor: 3.411

7.  A large French case-control study emphasizes the role of rare Mc1R variants in melanoma risk.

Authors:  Hui-Han Hu; Mériem Benfodda; Nicolas Dumaz; Steven Gazal; Vincent Descamps; Agnès Bourillon; Nicole Basset-Seguin; Angélique Riffault; Khaled Ezzedine; Martine Bagot; Armand Bensussan; Philippe Saiag; Bernard Grandchamp; Nadem Soufir
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

8.  Pigmentary Markers in Danes--Associations with Quantitative Skin Colour, Nevi Count, Familial Atypical Multiple-Mole, and Melanoma Syndrome.

Authors:  Peter Johansen; Jeppe Dyrberg Andersen; Linnea Nørgård Madsen; Henrik Ullum; Martin Glud; Claus Børsting; Robert Gniadecki; Niels Morling
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

9.  MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.

Authors:  Elena Pasquali; José C García-Borrón; Maria Concetta Fargnoli; Sara Gandini; Patrick Maisonneuve; Vincenzo Bagnardi; Claudia Specchia; Fan Liu; Manfred Kayser; Tamar Nijsten; Eduardo Nagore; Rajiv Kumar; Johan Hansson; Peter A Kanetsky; Paola Ghiorzo; Tadeusz Debniak; Wojciech Branicki; Nelleke A Gruis; Jiali Han; Terry Dwyer; Leigh Blizzard; Maria Teresa Landi; Giuseppe Palmieri; Gloria Ribas; Alexander Stratigos; M Laurin Council; Philippe Autier; Julian Little; Julia Newton-Bishop; Francesco Sera; Sara Raimondi
Journal:  Int J Cancer       Date:  2014-06-18       Impact factor: 7.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.